Improved extemporaneous formulation of cyclosporine ophthalmic drops
Mueller, D.W.
American Journal of Hospital Pharmacy 51(24): 3080-3081
1994
ISSN/ISBN: 0002-9289 PMID: 7856631 Document Number: 434781
Document emailed within 1 workday
Related Documents
Bertino, J.S.; Reed, M.D.; Lambert, P.W.; Halpin, T.C. 1981: Stability of an extemporaneous formulation of injectable cholecalciferol American Journal of Hospital Pharmacy 38(12): 1932-1933Alexander, K.S.; Thyagarajapuram, N. 2003: Formulation and accelerated stability studies for an extemporaneous suspension of amiodarone hydrochloride International Journal of Pharmaceutical Compounding 7(5): 389-393
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Lisi, D.M.; Fazio, A. 1991: Instructions provided by manufacturers for proper use of nonprescription ophthalmic drops American Journal of Hospital Pharmacy 48(5): 987-988
Arnold, M.; Wilkerson, M. 2017: A case of erythema multiforme major following administration of ciprofloxacin ophthalmic drops Dermatology Online Journal 23(10)
Zhang, J.M.; Lin, P.F.; Chen, L.L.; Tang, L.H.; Hong, X.Q.; Liang, B.X.; Chen, H.S.; Teng, L. 1993: Efficacy of xiaoxingzhang guttae ophthalmic eye drops in the treatment of experimental herpes simplex keratitis Zhongguo Zhong Yao Za Zhi 18(1): 49-52; 64
Verin, P.; Easty, D.L.; Secchi, A.; Ciprandi, G.; Partouche, P.; Nemeth-Wasmer, G.; Brancato, R.; Harrisberg, C.J.; Estivin-Ebrardt, C.; Coster, D.J.; Apel, A.J.; Coroneo, M.T.; Knorr, M.; Carmichael, T.R.; Kent-Smith, B.T.; Abrantes, P.; Leonardi, A.; Cerqueti, P.M.; Modorati, G.; Martinez, M. 2001: Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis American Journal of Ophthalmology 131(6): 691-698
Song, L.-n.; Li, H.-r.; Wang, H.-y.; Li, Z.; Zhao, W.-c.; Lu, F.-z.; Li, S.-m. 2016: Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate Yao Xue Xue Bao 51(10): 1622-1628
Baiza-Duran, L.M.; Quintana-Hau, J.; Tornero-Montaño, R.; Ortiz, M.I.; Castañeda-Hernández, G.; Alanis-Villarreal, L.; Avalos-Urzua, G.; Bustos-Zermeño, R.; Domene-Hinojosa, J.L.; Gómez-Bastar, P.; Ibañez-Hernandez, M.A.; Morales-Gómez, M.E.; Velasco-Gallegos, G.; Villar-Kuri, J. 2009: Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery International Journal of Clinical Pharmacology and Therapeutics 47(2): 89-95
Becouarn, G.; Duquesne, M.; Saint-André, J.P.; Bigorgne, J.C.; Arnaud, J.P.; Ronceray, J. 1996: Value of fine-needle aspiration and extemporaneous examination in thyroid surgery. a prospective study of 1235 fine-needle aspirations and extemporaneous examinations in 846 patients Journal de Chirurgie 133(5): 214-221
Kovarik, J.M.; Mueller, E.A.; Johnston, A.; Hitzenberger, G.; Kutz, K. 1993: Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation PharmacoTherapy 13(6): 613-617
Sansom, J.; Barnett, K.C.; Neumann, W.; Schulte-Neumann, A.; Clerc, B.; Jegou, J.P.; de Haas, V.; Weingarten, A. 1995: Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial Veterinary Record 137(20): 504-507
Laine, J.; Hoppu, K.; Jalanko, H.; Rönnholm, K.; Holmberg, C. 1997: Kidney function after 1:1 conversion to the cyclosporine microemulsion formulation in children with liver allografts Transplantation 63(12): 1768-1772
Foradori, A.C.; Martínez, L.; Vacarezza, A.; Elberg, L.; Loveluck, A.; Pinto, C. 1994: Pharmacokinetics of a new galenical formulation of oral cyclosporine a in stable kidney transplanted patients Transplantation Proceedings 26(5): 2969-2972
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315
Shah, A.K.; Sawchuk, R.J. 1988: Improved liquid-chromatographic determination of cyclosporine and its metabolites in blood Clinical Chemistry 34(7): 1467-1471
Ullah, M.; Shah, M.R.; Bin Asad, M.H.H.; Hasan, S.M.F.; Hussain, I. 2017: Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation Pakistan Journal of Pharmaceutical Sciences 30(6): 2139-2145
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068
Leino, M.; Carlson, C.; Jaanio, E.; Koivunen, T.; Lavikkala, H.; Riihelä, K.; Takalo, E. 1990: Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis Annals of Allergy 64(4): 398-402
Taesch, S.; Niese, D.; Mueller, E.A. 1994: Sandimmun neoral, a new oral formulation of cyclosporin a with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients Transplantation Proceedings 26(6): 3147-3149